Good morning, everyone, and welcome to another working week. The weekend respite went by rather quickly, yes? Well, it generally does. Nonetheless, we hope you enjoyed yourselves and prepared for another round of meetings, deadlines and whatever else may be lurking. To cope we are not only brewing cups of stimulation and purchased a new coffee kettle. Given our intake, we were overdue. So please join us. Meanwhile, here are some tidbits. Have a smashing day and do stay in touch…
Charlie Munger, who is Warren Buffett’s business partner, says Valeant Pharmaceuticals’ strategy of buying drugs and boosting prices may be legal, but is “deeply immoral”; The Securities and Exchange Commission is investigating whether Mylan failed to properly disclose real estate deals involving the company and its lead outside director; and a Pfizer plant in China that was inspected by FDA in order to ship drugs to the US kept a second set of quality and manufacturing records that didn’t match official ones.